BMEA STOCK ANALYSIS

Biomea Fusion Inc — price, returns and risk statistics

BMEABiomea Fusion Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel

Price summary

Last Close

1.41 $

Jul 2, 26

Market Cap

101.9 M $

Q1 2026 (TTM)

52-Week Range

0.96 $2.67 $

Return and risk cards

Total Return

%-14.5

Trailing 1-year performance

Volatility

%90.2

Price fluctuation measure

Sharpe Ratio

-0.16

Risk/Return ratio

Sortino Ratio

-0.17

Downside risk/return

Distance to Peak

%-47.2

Difference from 52-week peak

Maximum Drawdown

-%64.1

Deepest 1-year decline

Seasonality

Seasonality Chart

Year 2023
Year 2024
Year 2025
Current Period 2026
3/3 positive months

Periodic Returns

1M

+2.9%

3M

-8.4%

6M

+13.7%

YTD

+13.7%

1Y

-14.5%

3Y

-93.4%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date
BMEA+13.7%Gold-3.2%Silver-10.4%S&P 500+9.3%

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly positivity

Monthly Avg Positive/Negative Close

Positive Count
Negative Count
Average Positive %
Average Negative %

Frequently Asked Questions

What is the current Biomea Fusion Inc (BMEA) stock price?

BMEA last closed at 1.41 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the market capitalization of Biomea Fusion Inc?

Biomea Fusion Inc (BMEA) has a market capitalization of approximately 101.9 M $ as of the latest reported period.

Who are the main competitors of BMEA?

Key peers of Biomea Fusion Inc include RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S., Mesoblast Ltd, TELIX Pharmaceuticals Ltd. A detailed metric comparison is available on the Peers tab.

Go deeper on BMEA

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.